مباشر

Endpoints NewsGoHealth files for bankruptcy, as Medicare Advantage insurers pull back AgilentHow Investors May Respond To Agilent Technologies (A) Expanding AI-Enabled Lab Solutions And Oncology Diagnostics - simplywall.st BioPharma DiveTango data add to growing momentum for pancreatic cancer drugs Thermo FisherThermo Fisher Scientific Introduces New Mass Spectrometry Platforms and AI Software - Clinical Lab Products BioPharma DiveIncyte to buy blood disorder drug in possibly $2B deal FierceBiotechClinical-stage cancer biotech Treeline sees path to public markets via reverse merger FierceBiotechADA: Dexcom CGM shows benefit in non-insulin diabetes patients BioPharma DiveJ&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for up to $1B Endpoints NewsTreeline to go public via reverse merger with Standard BioTools Roche MediaThis Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug - Barron's BioPharma DiveADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option FierceBiotechResmed snaps up Noctrix Health in $340M sleep tech deal

Endpoints News ٨ يونيو ٢٠٢٦

Biopharma's top-paid CEOs of 2025: 25 making $25M+

For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no longer rich...

For the first time in four years, Endpoints News is raising the bar for what it means to be a top-paid CEO. The previous floor of $20 million is no longer rich enough. The biopharma ...